Trump-Xi Summit Puts ASML's China Policy Risk in Spotlight

What happened

The high-stakes Trump-Xi summit in Beijing intensifies focus on ASML, whose China exposure (29.1% of 2025 sales) makes it a key proxy for trade and export-control outcomes. The meeting's agenda—tariffs, AI, Taiwan, rare earths—directly touches the semiconductor supply chain where ASML's lithography tools are critical. ASML's management has repeatedly stated its 2026 guidance range already accommodates potential export-control outcomes, but proposals for a countrywide immersion DUV restriction remain a live risk. A détente could remove a key overhang and support the stock's already elevated valuation (50.8x P/E), while escalation toward tighter controls would threaten both new system shipments and installed-base service revenue. The stock's current price of $1,592 sits above the $1,400 attractive entry identified in DeepValue analysis, leaving limited margin of safety and making outcome-sensitive positioning crucial.

Implication

The meeting outcome will likely set the near-term policy trajectory. If the result eases restrictions, ASML could re-rate toward $1,650 base case; if they tighten, the stock could test $1,400 support or lower. Position sizes should reflect this binary risk.

Thesis delta

The Trump-Xi summit introduces a near-term binary catalyst that could either validate the current policy status quo (supporting the base case) or trigger a step-change in export controls. The base case already assumes 'manageable' controls, so a material easing would be a positive surprise, while escalation would invalidate that assumption. This elevates the near-term uncertainty beyond what the standard 3-6 month reassessment window captured.